- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Astellas Pharma Inc (4503)
| Open: | 5,700 | Day's Range: | 5,650 - 5,800 | Volume: | 2,100,000 |
|---|---|---|---|---|---|
| Previous Close: | 5,690 | 52wk Range: | 3,020 - 6,010 | 1-Yr Rtn: | +93.74% |
Key Statistics for 4503
| Current P/E Ratio (ttm) | 32.0049 |
|---|---|
| Estimated P/E(03/2014) | 20.9534 |
| Relative P/E vs. TPX | 1.2917 |
| Earnings Per Share (JPY) (ttm) | 179.6600 |
| Est. EPS (JPY) (03/2014) | 274.4190 |
| Est. PEG Ratio | 1.3895 |
| Market Cap (M JPY) | 2,690,796.75 |
| Shares Outstanding (M) | 467.96 |
| 30 Day Average Volume | 2,015,067 |
| Price/Book (mrq) | 2.4428 |
| Price/Sale (ttm) | 2.6256 |
| Dividend Indicated Gross Yield | 2.35% |
| Cash Dividend (JPY) | 65.0000 |
| Last Dividend | 09/26/2013 |
| 5 Year Dividend Growth | 3.40% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4503
Company Profile & Key Executives for 4503
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
| Masafumi NogimoriChairman | Yasuo IshiiVice Chairman |
| Yoshihiko HatanakaPresident/CEO | Sef KurstjensChief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4503 News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page